The results of the investigation are inconclusive at this time, and the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history and sterilization record for this device serial number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.An external physician expert reviewed the event, and in the expert's opinion, it was strange that the doctor reported the syncope may be related to the cvrx device but haven't attempted to adjust barostim therapy settings to address the event; and, it was also strange that the managing physician reported they implanted an icd to help address the syncope when an icd is primarily a rescue device for patients with tachycardia, and not really indicated for syncope.Cvrx id# (b)(4).
|
A barostim system was implanted on (b)(6) 2022.In (b)(6) 2022, the patient started to experience syncope.It was noted that the patient experienced syncope approximately seven times.A dual chamber icd was placed on (b)(6) 2023, and the patient was discharged on (b)(6) 2023.There were no adjustments made to the barostim system.The physician was unable to determine the cause of the syncope or determine if the barostim system was contributory.It was noted that the patient had multiple physicians changing their medications without communication or consult with their cardiologist and the patient had experienced instances of dehydration.
|